United States Spirometer Market Size, Share, and COVID-19 Impact Analysis, By Technology (Volume Measurement, Flow Measurement, and Peak Flow Measurement), By Application (Asthma, COPD, Cystic Fibrosis, Pulmonary Fibrosis, and Others), and United States Spirometer Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jul 2025
REPORT ID SI13090
PAGES 163
REPORT FORMAT PathSoft

United States Spirometer Market Size Insights Forecasts to 2035

  • The US Spirometer Market Size Was Estimated at USD 425.9 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 8.82% from 2025 to 2035
  • The US Spirometer Market Size is Expected to Reach USD 1078.9 Million by 2035

United States Spirometer Market

Get more details on this report -

Request Free Sample PDF

According to a Research Report Published by Spherical Insights & Consulting, the United States Spirometer Market Size is anticipated to reach USD 1078.9 Million by 2035, growing at a CAGR of 8.82% from 2025 to 2035. The expansion of the United States spirometer market is propelled by chronic respiratory disease prevalence is rising, home healthcare is becoming more popular, and technology is advancing.

 

Market Overview

A medical device called a spirometer is used to measure the amount of air that the lungs inhale and exhale, usually as part of pulmonary function examinations. A spirometer is a diagnostic instrument used to perform simple lung function tests to help diagnose respiratory diseases, such as asthma and chronic obstructed pulmonary disease (COPD), etc. Furthermore, participants in the market are focused on developing innovative hardware and software to increase diagnosis rates for the disease, which is expected to create additional demand for such goods across the country. Also, there are tools, for example, incentive spirometers, that are easily employable in pulmonary rehabilitation, that collect data on the volume of air inhaled during an inspiration. The availability of multi-purpose goods will likely increase use among patients with respiratory diseases. The likely increased incidence of these diseases will likely create more demand for early diagnosis, thus encouraging increased demand for diagnostic devices such as incentive spirometers.

 

The United States Government is pursuing a program of enhanced innovation to promote pulmonary function testing (PFT) and the use of spirometer technologies, which include traditional funding, training, standards development, and licensing procedures for devices.

 

Report Coverage

This research report categorizes the market for the United States spirometer market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States spirometer market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States spirometer market.

 

United States Spirometer Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 425.9 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :8.82%
2035 Value Projection:USD 1078.9 Million
Historical Data for:2020-2023
No. of Pages:163
Tables, Charts & Figures:122
Segments covered:By Technology, By Application and COVID-19 Impact Analysis
Companies covered::NSPIRE Healthcare, Vyaire Medical, Welch Allyn, MGC Diagnostics Corporation, Hill-Rom, Inc., Midmark Corporation, Futuremed, MGC Diagnostics Corporation, Jones Medical Instrument Company, and Other key vendors
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The growth of the United States spirometer market is boosted by advances in sensor accuracy, portability, and cloud-based data analytics, as well as a rise in respiratory conditions such as asthma, COPD, cystic fibrosis, the need for early diagnosis and preventive healthcare, integration with EHR systems, the emergence of telemedicine and home-use devices with smartphone connectivity. During the forecast period, growth in the market in the U.S. is likely to occur from the increased emphasis on rapid diagnostic tests, which are expected to raise rates of diagnosis and increase demand for diagnostic products.

 

Restraining Factors

The United States spirometer market faces obstacles like a lack of trained human resources to facilitate testing. Healthcare workers are not sufficiently trained or possess the knowledge to utilize these platforms.

 

Market Segmentation

The United States spirometer market share is classified into technology and application.

 

  • The flow measurement segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period.

The United States spirometer market is segmented by technology into volume measurement, flow measurement, and peak flow measurement. Among these, the flow measurement segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period. The segment is driven by many applications of pulmonary function tests. Spirometry devices, as there are no mechanical components, are typically tabletop-based, and they are simple to use.

 

  • The COPD segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

Based on the application, the United States spirometer market is segmented into asthma, COPD, cystic fibrosis, pulmonary fibrosis, and other. Among these, the COPD segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is propelled by millions of people who are affected by mild to severe COPD, and spirometry makes it easier to diagnose COPD.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States spirometer market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • NSPIRE Healthcare
  • Vyaire Medical
  • Welch Allyn
  • MGC Diagnostics Corporation
  • Hill-Rom, Inc.
  • Midmark Corporation
  • Futuremed
  • MGC Diagnostics Corporation
  • Jones Medical Instrument Company
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the United States, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States spirometer market based on the following segments:

 

United States Spirometer Market, By Technology

  • Volume Measurement
  • Flow Measurement
  • Peak Flow Measurement

 

United States Spirometer Market, By Application

  • Asthma
  • COPD
  • Cystic Fibrosis
  • Pulmonary Fibrosis
  • Others

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies